ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 115 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2020. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,000 | -33.3% | 200 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -40.0% | 200 | 0.0% | 0.00% | – |
| Q1 2022 | $5,000 | -28.6% | 200 | 0.0% | 0.00% | – |
| Q4 2021 | $7,000 | -22.2% | 200 | 0.0% | 0.00% | – |
| Q3 2021 | $9,000 | +50.0% | 200 | 0.0% | 0.00% | – |
| Q2 2021 | $6,000 | -25.0% | 200 | 0.0% | 0.00% | – |
| Q1 2021 | $8,000 | -88.1% | 200 | -96.0% | 0.00% | – |
| Q1 2020 | $67,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 8,394 | $264,663 | 0.19% |
| Global Wealth Strategies & Associates | 100 | $3,153 | 0.00% |